Molecular stability and function of hemoglobins Hasharon (alpha(2)47 (CD5)Asp----His beta 2) and Hasharon (alpha(2)47 (CD5)Asp----His delta 2).
The molecular stability and function of hemoglobin (Hb) Hasharon (alpha 2 H beta 2) and Hb Hasharon2 (alpha 2 H delta 2) were studied and compared to Hbs A, A2 and S. Hb Hasharon and Hb Hasharon2 had slightly lower P50 values than Hb A and Hb A2 but had normal responses to organic phosphates. The molecular stability of Hb Hasharon and Hb Hasharon2 (as measured by mechanical shaking and heat denaturation at 60 degrees C) were less than Hb A and Hb A2 but greater than Hb S in the oxy- and carbonmonoxy-forms. In the met-form, however, Hb Hasharon and Hb Hasharon2 were less stable than hemoglobins S, A and A2. The oxy-form of Hb Hasharon forms methemoglobin at a faster rate than Hb A and Hb S. The mechanical and heat stabilities and the rate of methemoglobin formation of oxy-Hb Hasharon were studied in the presence of sulfisoxazole. This drug increased the rate of methemoglobin formation, thus causing a further decrease in the stability of Hb Hasharon. The relationship between these laboratory findings and previously observed clinical findings associated with Hb Hasharon are discussed.
D000293:Adolescent; D002263:Carboxyhemoglobin / Q000378:metabolism; D006441:Hemoglobin A / Q000378:metabolism*; D006443:Hemoglobin A2 / Q000378:metabolism*; D006451:Hemoglobin, Sickle / Q000378:metabolism; D006455:Hemoglobins, Abnormal / Q000378:metabolism*; D006801:Humans; D008297:Male; D008706:Methemoglobin / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D010108:Oxyhemoglobins / Q000378:metabolism; D011489:Protein Denaturation; D013444:Sulfisoxazole / Q000494:pharmacology
D006451:Hemoglobin, Sickle; D006455:Hemoglobins, Abnormal; D010108:Oxyhemoglobins; C029985:hemoglobin Sealy; D013444:Sulfisoxazole; D008706:Methemoglobin; D006441:Hemoglobin A; D006443:Hemoglobin A2; D002263:Carboxyhemoglobin; D010100:Oxygen